The preventive effects of nirsevimab against respiratory syncytial virus infection persisted for up to 12 months after ...

Older adults may have unique health and safety concerns, but this advice on what to pack, how to prepare and navigating ...

Experts reveal the signs that you're no longer at risk of spreading illnesses like COVID, flu and strep throat to others.

Researchers found differences in how respiratory syncytial virus spreads among children in rural versus urban communities and ...

Cold and flu season typically happen during the fall and winter. Though it comes around every year, there's still a lot of ...

The RSV shot isn't suggested for everyone like the flu vaccine is. Here's who is at risk and how to get a shot.

Providing year-round access to RSV immunization would minimize the risk of large seasonal outbreaks across the nation, ...

The main market opportunities in the RSV prophylaxis field lie in the development of new monoclonal antibodies and vaccines, with substantial growth expected due to late-stage pipeline products. This ...

Health officials say they expect a pretty robust triple threat this season: RSV, influenza and pneumonia. Illness seems to ...

AS HOLIDAY TRAVEL SURGES, SO DOES THE RISK OF CATCHING AND SPREADING RESPIRATORY VIRUSES LIKE FLU, COVID-19, AND RESPIRATORY ...

As respiratory viruses increase this winter, New Jersey residents are reminded to protect vulnerable populations from RSV, ...

Sanofi and AstraZeneca's Beyfortus (Nirsevimab) is now approved by the National Pharmaceutical Regulatory Agency (NPRA) and is available for the prevention of respiratory syncytial virus (RSV) lower ...